82 FR 13120 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 45 (March 9, 2017)

Page Range		13120-13120
FR Document		2017-04624

Federal Register, Volume 82 Issue 45 (Thursday, March 9, 2017)

[Federal Register Volume 82, Number 45 (Thursday, March 9, 2017)]
[Notices]
[Page 13120]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04624]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
DP17-003, Natural Experiments of Policy and Built Environment Impact on 
Diabetes Risk.
    Times and Dates:

10:00 a.m.-6:00 p.m., EDT, April 12, 2017 (Closed)
10:00 a.m.-6:00 p.m., EDT, April 13, 2017 (Closed)


    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Natural Experiments of Policy and Built Environment Impact on 
Diabetes Risk'', FOA D P17-003.
    Contact Person for More Information: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-04624 Filed 3-8-17; 8:45 am]
 BILLING CODE 4163-18-P

13120 Federal Register / Vol. 82, No. 45 / Thursday, March 9, 2017 / Notices

DEPARTMENT OF HEALTH AND accommodates approximately 60 Times and Dates:
HUMAN SERVICES people. Advance registration for in- 10:00 a.m.–6:00 p.m., EDT, April 12,
person participation is required by April 2017 (Closed)
Centers for Disease Control and 5, 2017. The public is welcome to 10:00 a.m.–6:00 p.m., EDT, April 13,
Prevention participate during the public comment 2017 (Closed)
period, which is tentatively scheduled
Advisory Council for the Elimination of from 3:45 p.m. to 3:55 p.m. This Place: Teleconference.
Tuberculosis: Notice of Charter meeting will also be available by Status: The meeting will be closed to
Renewal teleconference. Please dial (866) 918– the public in accordance with
8397 and enter code 9346283. provisions set forth in Section 552b(c)
This gives notice under the Federal (4) and (6), Title 5 U.S.C., and the
Advisory Committee Act (Pub. L. 92– Purpose: The Subcommittee will
provide advice to the CDC Director Determination of the Director,
463) of October 6, 1972, that the Management Analysis and Services
Advisory Council for the Elimination of through the ACD on strategic and other
health disparities and health equity Office, CDC, pursuant to Public Law 92–
Tuberculosis, Department of Health and 463.
Human Services, has been renewed for issues and provide guidance on
opportunities for CDC. Matters for Discussion: The meeting
a 2-year period through March 15, 2019. will include the initial review,
For information, contact Hazel Dean, Matters for Discussion: The Health
Disparities Subcommittee members will discussion, and evaluation of
Sc.D., M.P.H., Designated Federal
receive an update on selected applications received in response to
Officer, Advisory Council for the
recommendations of the HDS, and on ‘‘Natural Experiments of Policy and
Elimination of Tuberculosis,
progress toward Health Equity and Built Environment Impact on Diabetes
Department of Health and Human
Public Health Accreditation. Risk’’, FOA D P17–003.
Services, 1600 Clifton Road NE.,
Agenda items are subject to change as Contact Person for More Information:
Mailstop E–10, Atlanta, Georgia 30333,
priorities dictate. Jaya Raman Ph.D., Scientific Review
telephone 404/639–8000 or fax 404/
Contact Person for More Information: Officer, CDC, 4770 Buford Highway,
639–8600.
The Director, Management Analysis Leandris Liburd, Ph.D., M.P.H., M.A., Mailstop F80, Atlanta, Georgia 30341,
and Services Office, has been delegated Designated Federal Officer, Health Telephone: (770) 488–6511, kva5@
the authority to sign Federal Register Disparities Subcommittee, Advisory cdc.gov.
notices pertaining to announcements of Committee to the Director, CDC, 1600 The Director, Management Analysis
meetings and other committee Clifton Road NE., M/S K–77, Atlanta, and Services Office, has been delegated
management activities, for both the Georgia 30329. Telephone (404) 498– the authority to sign Federal Register
Centers for Disease Control and 6482, Email: ACDirector@cdc.gov. notices pertaining to announcements of
Prevention and the Agency for Toxic The Director, Management Analysis meetings and other committee
Substances and Disease Registry. and Services Office, has been delegated management activities, for both the
the authority to sign Federal Register Centers for Disease Control and
Elaine L. Baker, notices pertaining to announcements of Prevention and the Agency for Toxic
Director, Management Analysis and Services meetings and other committee Substances and Disease Registry.
Office, Centers for Disease Control and management activities, for both the
Prevention. Elaine L. Baker,
Centers for Disease Control and
[FR Doc. 2017–04616 Filed 3–8–17; 8:45 am] Director, Management Analysis and Services
Prevention and the Agency for Toxic Office, Centers for Disease Control and
BILLING CODE 4163–18–P Substances and Disease Registry. Prevention.
Elain L. Baker, [FR Doc. 2017–04624 Filed 3–8–17; 8:45 am]
DEPARTMENT OF HEALTH AND Director, Management Analysis and Services BILLING CODE 4163–18–P
HUMAN SERVICES Office, Centers for Disease Control and
Prevention (CDC).
Centers for Disease Control and [FR Doc. 2017–04619 Filed 3–8–17; 8:45 am] DEPARTMENT OF HEALTH AND
Prevention BILLING CODE 4163–18–P HUMAN SERVICES

Advisory Committee to the Director Centers for Disease Control and
(ACD), Centers for Disease Control and DEPARTMENT OF HEALTH AND Prevention
Prevention (CDC)—Health Disparities HUMAN SERVICES
Subcommittee (HDS) Disease, Disability, and Injury
Centers for Disease Control and Prevention and Control Special
In accordance with section 10(a)(2) of Prevention Emphasis Panel (SEP): Initial Review
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease In accordance with Section 10(a)(2) of
Disease, Disability, and Injury
Control and Prevention (CDC) the Federal Advisory Committee Act
Prevention and Control Special
announces the following meeting of the (Pub. L. 92–463), the Centers for Disease
Emphasis Panel (SEP): Initial Review
aforementioned committee: Control and Prevention (CDC)
Time and Date: 8:30 p.m.–4:00 p.m., In accordance with Section 10(a)(2) of announces a meeting for the initial
the Federal Advisory Committee Act review of applications in response to
asabaliauskas on DSK3SPTVN1PROD with NOTICES

EDT, April 19, 2017.
Place: Centers for Disease Control & (Pub. L. 92–463), the Centers for Disease Funding Opportunity Announcement
Prevention (CDC), Global Control and Prevention (CDC) (FOA) DP17–002, Validation of Survey
Communications Center, Building 19, announces a meeting for the initial Questions to Distinguish Type 1 and
Rooms 254/255, 1600 Clifton Road NE., review of applications in response to Type 2 Diabetes among Adults with
Atlanta, Georgia 30329. Funding Opportunity Announcement Diabetes.
Status: Open to the public, limited (FOA) DP17–003, Natural Experiments Time and Date: 10:00 a.m.–6:00 p.m.,
only by the space and phone lines of Policy and Built Environment Impact EDT, April 5, 2017 (Closed).
available. The meeting room on Diabetes Risk. Place: Teleconference.

VerDate Sep<11>2014 17:43 Mar 08, 2017 Jkt 241001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM 09MRN1

Document Created: 2017-03-09 04:59:19
Document Modified: 2017-03-09 04:59:19

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
FR Citation		82 FR 13120

82 FR 13120 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 82, Issue 45 (March 9, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention